Ermer, James C.

Lisdexamfetamine Dimesylate: Linear Dose‐Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open‐Label Single‐Dose Pharmacokinetic Study in Healthy Adult Volunteers

Ermer, J., Homolka, R., Martin, P., Buckwalter, M., Purkayastha, J., & Roesch, B. (2010) · The Journal of Clinical Pharmacology

Attention Deficit Hyperactivity DisorderPharmacogenetics and Drug Metabolism

Cited by 72

Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy

Ermer, J. C., Pennick, M., & Frick, G. (2016) · Clinical Drug Investigation

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 67

Intranasal versus Oral Administration of Lisdexamfetamine Dimesylate: A Randomized, Open-Label, Two-Period, Crossover, Single-Dose, Single-Centre Pharmacokinetic Study in Healthy Adult Men

Ermer, J. C., Dennis, K., Haffey, M. B., Doll, W. J., Sandefer, E. P., Buckwalter, M., Page, R. C., Diehl, B., & Martin, P. T. (2011) · Clinical Drug Investigation

Pharmacogenetics and Drug MetabolismPharmacology and Obesity Treatment

Cited by 35

Pharmacokinetics of Lisdexamfetamine Dimesylate after Targeted Gastrointestinal Release or Oral Administration in Healthy Adults

Ermer, J. C., Haffey, M. B., Doll, W. J., Martin, P., Sandefer, E. P., Dennis, K., Corcoran, M., Trespidi, L., & Page, R. C. (2012) · Drug Metabolism and Disposition

Pharmacology and Obesity TreatmentPharmacogenetics and Drug Metabolism

Cited by 22

Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults

Ermer, J., Richards, Lasseter, K., Adeyi, Corcoran, Martin, P., & Stanton, B. (2013) · Neuropsychiatric Disease and Treatment

Pharmaceutical studies and practicesAttention Deficit Hyperactivity Disorder

Cited by 19